Protective effects of propionyl-L-carnitine during ischemia and reperfusion

A. Shug, D. Paulson, Ramiah Subramanian, V. Regitz

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.

Original languageEnglish (US)
Pages (from-to)77-83
Number of pages7
JournalCardiovascular Drugs and Therapy
Volume5
Issue number1 Supplement
DOIs
StatePublished - Feb 1 1991

Fingerprint

propionylcarnitine
Carnitine
Reperfusion
Ischemia
Acetylcarnitine
Fatty Acids

Keywords

  • free radicals
  • ischemia
  • propionyl-L-carnitine
  • reperfusion fatty acids

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Protective effects of propionyl-L-carnitine during ischemia and reperfusion. / Shug, A.; Paulson, D.; Subramanian, Ramiah; Regitz, V.

In: Cardiovascular Drugs and Therapy, Vol. 5, No. 1 Supplement, 01.02.1991, p. 77-83.

Research output: Contribution to journalArticle

Shug, A, Paulson, D, Subramanian, R & Regitz, V 1991, 'Protective effects of propionyl-L-carnitine during ischemia and reperfusion', Cardiovascular Drugs and Therapy, vol. 5, no. 1 Supplement, pp. 77-83. https://doi.org/10.1007/BF00128246
Shug, A. ; Paulson, D. ; Subramanian, Ramiah ; Regitz, V. / Protective effects of propionyl-L-carnitine during ischemia and reperfusion. In: Cardiovascular Drugs and Therapy. 1991 ; Vol. 5, No. 1 Supplement. pp. 77-83.
@article{a139bf7362684a5f86b09dbd02ad76db,
title = "Protective effects of propionyl-L-carnitine during ischemia and reperfusion",
abstract = "When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.",
keywords = "free radicals, ischemia, propionyl-L-carnitine, reperfusion fatty acids",
author = "A. Shug and D. Paulson and Ramiah Subramanian and V. Regitz",
year = "1991",
month = "2",
day = "1",
doi = "10.1007/BF00128246",
language = "English (US)",
volume = "5",
pages = "77--83",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "1 Supplement",

}

TY - JOUR

T1 - Protective effects of propionyl-L-carnitine during ischemia and reperfusion

AU - Shug, A.

AU - Paulson, D.

AU - Subramanian, Ramiah

AU - Regitz, V.

PY - 1991/2/1

Y1 - 1991/2/1

N2 - When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.

AB - When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.

KW - free radicals

KW - ischemia

KW - propionyl-L-carnitine

KW - reperfusion fatty acids

UR - http://www.scopus.com/inward/record.url?scp=0025778490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025778490&partnerID=8YFLogxK

U2 - 10.1007/BF00128246

DO - 10.1007/BF00128246

M3 - Article

VL - 5

SP - 77

EP - 83

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 1 Supplement

ER -